Navamedic ASA Total Assets

Latest as of June 2026: Nkr656.62 Million NOK ≈ $69.10 Million USD

Navamedic ASA total assets. Based on the latest financial reports, Navamedic ASA (NAVA) holds total assets worth Nkr656.62 Million NOK (≈ $69.10 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see cash flow conversion of Navamedic ASA for how efficiently the company converts equity into cash flow.

Total Assets of Navamedic ASA (2003–2025)

Total assets of Navamedic ASA from 2003 to 2025. This chart illustrates how Navamedic ASA's total assets have evolved over time, based on quarterly financial data. See Navamedic ASA (NAVA) stock price for real-time trading data and today's change.

Navamedic ASA - Asset Composition Analysis

Navamedic ASA Total Assets Breakdown (December 2025)

Navamedic ASA total assets breakdown as of December 2025. Navamedic ASA's total assets of Nkr656.62 Million consist of 36.7% current assets and 63.4% non-current assets. Explore NAVA net working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Asset Category Amount (NOK) % of Total Assets
Cash & Equivalents Nkr72.57 Million 9.8%
Accounts Receivable Nkr43.30 Million 5.8%
Inventory Nkr116.56 Million 15.7%
Property, Plant & Equipment Nkr6.19 Million 0.8%
Intangible Assets Nkr250.89 Million 33.8%
Goodwill Nkr207.57 Million 28.0%

Asset Composition Trend (2003–2025)

This chart illustrates how Navamedic ASA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Navamedic ASA's current assets represent 36.7% of total assets in 2025, a decrease from 51.8% in 2003.
  • Cash Position: Cash and equivalents constituted 9.8% of total assets in 2025, down from 335.6% in 2003.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 60.0% of total assets, an increase from 30.0% in 2003.
  • Asset Diversification: The largest asset category is intangible assets at 33.8% of total assets.

Navamedic ASA Competitors by Total Assets

Key competitors of Navamedic ASA based on total assets are shown below.

Company Country Total Assets
CLOUDR GROUP LTD.
F:H3L
Germany €2.15 Billion
Farmaceutica R
RO:RMAH
Romania RON345.32 Million
Sigma Healthcare Ltd
AU:SIG
Australia AU$8.74 Billion
Ebos Group Ltd
AU:EBO
Australia AU$8.80 Billion
Paragon Care Ltd
AU:PGC
Australia AU$1.31 Billion
Mayne Pharma Group Ltd
AU:MYX
Australia AU$1.01 Billion
Millennium Pharmacon International
JK:SDPC
Indonesia Rp1.90 Trillion
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
Brazil R$5.64 Billion

Navamedic ASA - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.47 1.30 1.13
Quick Ratio 0.74 0.71 0.58
Cash Ratio 0.00 0.25 0.17
Working Capital Nkr74.89 Million Nkr50.72 Million Nkr17.28 Million

Navamedic ASA - Advanced Valuation Insights

This section examines the relationship between Navamedic ASA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.06
Latest Market Cap to Assets Ratio 0.04
Asset Growth Rate (YoY) 51.0%
Total Assets Nkr741.75 Million
Market Capitalization $27.76 Million USD

Valuation Analysis

Below Book Valuation: The market values Navamedic ASA's assets below their book value (0.04x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Navamedic ASA's assets grew by 51.0% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Navamedic ASA (2003–2025)

The table below shows the annual total assets of Navamedic ASA from 2003 to 2025.

Year Total Assets Change
2025-12-31 Nkr741.75 Million
≈ $78.05 Million
+50.99%
2024-12-31 Nkr491.24 Million
≈ $51.69 Million
-6.31%
2023-12-31 Nkr524.30 Million
≈ $55.17 Million
+36.98%
2022-12-31 Nkr382.77 Million
≈ $40.28 Million
+15.93%
2021-12-31 Nkr330.18 Million
≈ $34.74 Million
+26.97%
2020-12-31 Nkr260.04 Million
≈ $27.36 Million
+39.02%
2019-12-31 Nkr187.06 Million
≈ $19.68 Million
-12.89%
2018-12-31 Nkr214.73 Million
≈ $22.60 Million
-13.16%
2017-12-31 Nkr247.27 Million
≈ $26.02 Million
-14.04%
2016-12-31 Nkr287.67 Million
≈ $30.27 Million
+4.40%
2015-12-31 Nkr275.55 Million
≈ $29.00 Million
+29.24%
2014-12-31 Nkr213.20 Million
≈ $22.44 Million
+18.79%
2013-12-31 Nkr179.48 Million
≈ $18.89 Million
+34.19%
2012-12-31 Nkr133.75 Million
≈ $14.07 Million
-3.83%
2011-12-31 Nkr139.07 Million
≈ $14.63 Million
+12.77%
2010-12-31 Nkr123.33 Million
≈ $12.98 Million
-9.69%
2009-12-31 Nkr136.55 Million
≈ $14.37 Million
-14.47%
2008-12-31 Nkr159.65 Million
≈ $16.80 Million
-13.92%
2007-12-31 Nkr185.46 Million
≈ $19.52 Million
+253.76%
2006-12-31 Nkr52.42 Million
≈ $5.52 Million
+9.23%
2005-12-31 Nkr47.99 Million
≈ $5.05 Million
+180.89%
2004-12-31 Nkr17.09 Million
≈ $1.80 Million
+2116.74%
2003-12-31 Nkr770.79K
≈ $81.11K
--

About Navamedic ASA

OL:NAVA Norway Medical Distribution
Market Cap
$27.76 Million
Nkr263.80 Million NOK
Market Cap Rank
#23909 Global
#221 in Norway
Share Price
Nkr11.00
Change (1 day)
-17.91%
52-Week Range
Nkr11.00 - Nkr26.00
All Time High
Nkr42.60
About

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. Its product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. The company offers medical nutrition… Read more